MARKET

PBE

PBE

Invesco Biotechnology & Genome ETF
NYSEARCA
89.69
+1.58
+1.79%
After Hours: 89.69 0 0.00% 16:10 06/26 EDT
OPEN
88.12
PREV CLOSE
88.11
HIGH
90.33
LOW
88.12
VOLUME
14.66K
TURNOVER
--
52 WEEK HIGH
90.33
52 WEEK LOW
61.44
TOTAL ASSET
277.44M
YTD YIELD
42.65%
1D
5D
1M
3M
1Y
5Y
1D
The Disinflation Trade Has A New Address: Genomics
Seeking Alpha · 19h ago
Merck's Bio-Techne buyout put Life Sciences sector in focus: top quant-rated stocks
Seeking Alpha · 1d ago
Biotech breakout: iShares Biotechnology ETF hits all-time high
Seeking Alpha · 3d ago
Healthcare's Quiet Comeback: Innovation, Obesity Drugs And New Opportunities
Seeking Alpha · 3d ago
As AbbVie eyes Apogee, these biotech stocks earn the highest Quant ratings
Seeking Alpha · 5d ago
Invesco Biotechnology & Genome ETF declares quarterly distribution of $0.8106
Seeking Alpha · 5d ago
Weekly Report: what happened at PBE last week (0615-0619)?
Weekly Report · 5d ago
Weekly Report: what happened at PBE last week (0608-0612)?
Weekly Report · 06/15 09:45
More
Profile
Fund Name
Invesco Biotechnology & Genome ETF
Inception Date
2005-06-23
Benchmark
Dynamic Biotech&Genome Intellidex TR USD
Advisor Company
Invesco
Custodian
The Bank of New York Mellon
Manager
Peter Hubbard, Michael Jeanette, Tony Seisser, Pratik Doshi